Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers.
BACKGROUND
Cigarette smoking has been associated with increases in C-reactive protein (CRP) and leukocyte counts (white blood cell [WBC]); however, the effects of smoking intensity and smoking cessation on inflammatory markers have not been evaluated prospectively in a large, modern cohort of current smokers.


METHODS
White blood cell count and high-sensitivity CRP were measured in current smokers enrolled in a randomized, prospective clinical trial of 5 smoking cessation pharmacotherapies. Smoking intensity parameters included cigarettes per day, pack-years, Fagerström Test of Nicotine Dependence score, and carbon monoxide levels. C-reactive protein also was measured after 1 year with assessment of abstinence status.


RESULTS
The 1,504 current smokers (58% female) were (mean [SD]) 44.7 (11.1) years old, smoked 21.4 (8.9) cigarettes per day, and had a smoking burden of 29.4 (20.4) pack-years. Log(CRP) was not associated with any marker of smoking intensity, except for a weak correlation with pack-years (r = 0.05, P = .047). In contrast, statistically significant correlations were observed between all 4 markers of smoking intensity and WBC count (all P ≤ .011). In multivariable models, waist circumference (P < .001) and triglycerides (P < .05), but no markers of smoking intensity, were associated with log(CRP). However, pack-years (P = .002), cigarettes per day (P = .013), carbon monoxide (P < .001), and Fagerström Test of Nicotine Dependence (P < .001) were independently associated with WBC count. After 1 year, log(CRP) (P = .296) and changes in log(CRP) (P = .455) did not differ between abstainers and continuing smokers.


CONCLUSIONS
Smoking intensity is associated with increased WBC count, but not CRP levels. Smoking cessation does not reduce CRP. The relationship between CRP and smoking intensity may be masked by CRP's stronger relationship with adiposity.
Asthana
Asha
A
University of Wisconsin School of Medicine and Public Health, Madison, 53792, USA.
Johnson
Heather M
HM
Piper
Megan E
ME
Fiore
Michael C
MC
Baker
Timothy B
TB
Stein
James H
JH
D000328:Adult; D002097:C-Reactive Protein / Q000032:analysis*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D012907:Smoking / Q000097:blood*; D016540:Smoking Cessation / Q000379:methods
D002097:C-Reactive Protein
N Engl J Med. 1990 Jan 25;322(4):213-7
2294448
BMJ. 2004 Jun 26;328(7455):1519
15213107
JAMA. 1998 May 13;279(18):1477-82
9600484
Psychol Bull. 1992 Jan;111(1):23-41
1539088
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
12900694
J Am Coll Cardiol. 2010 May 4;55(18):1988-95
20236788
Br J Addict. 1991 Sep;86(9):1119-27
1932883
Arch Gen Psychiatry. 2009 Nov;66(11):1253-62
19884613
Eur Heart J. 2005 Sep;26(17):1765-73
15817606
Int J Epidemiol. 1990 Dec;19(4):881-8
2084016
Circulation. 2003 Jan 28;107(3):499-511
12551878
Nicotine Tob Res. 2008 Apr;10(4):637-42
18418786
Am J Public Health. 2009 Jul;99(7):1263-70
18923113
JAMA. 2006 Jul 5;296(1):56-63
16820547
Lancet. 2004 Sep 11-17;364(9438):937-52
15364185
Psychiatry Res. 2010 Jan 30;175(1-2):133-7
19969373
Circ J. 2006 Jan;70(1):8-13
16377917
N Engl J Med. 1985 Dec 12;313(24):1511-4
4069159
Prev Med. 2005 Aug;41(2):651-6
15917065
Ann Intern Med. 2003 Jun 3;138(11):891-7
12779299
Nicotine Tob Res. 2002 Aug;4(3):287-94
12215237
Arch Intern Med. 2005 Oct 10;165(18):2063-8
16216995
Am J Cardiol. 2002 May 1;89(9):1117-9
11988205
Am J Cardiol. 1999 Nov 1;84(9):1018-22
10569656
JAMA. 2006 Jul 5;296(1):47-55
16820546
Ann Epidemiol. 1993 Jul;3(4):417-24
8275219
Int J Epidemiol. 2005 Apr;34(2):268-75
15319403
J Clin Lipidol. 2009 Dec;3(6):372-8
20161531